Xue-Xin Cheng
7PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jan 12, 2026
Cancer-derived inflammation is associated with bevacizumab resistance and inferior clinical outcomes in patients with metastatic colorectal cancer.Ya-Nan Li, Yang Wu, Feng-Wen Deng
|Mar 20, 2025
Robust Predictive Performance of MLPAS and CCMLP for Clinical Outcome and Risk Stratification in Patients with Colorectal Cancer.Qiu-Ying Ye, Yuan-Yuan Wang, Zhi-Jie Wang
|Mar 29, 2022
Quantification of fibrinogen-to-pre-albumin ratio provides an integrating parameter for differential diagnosis and risk stratification of early-stage colorectal cancer.Hou-Qun Ying, Wei Chen, Cui-Fen Xiong
|Jul 15, 2021
The value of circulating fibrinogen-to-pre-albumin ratio in predicting survival and benefit from chemotherapy in colorectal cancer.Hou-Qun Ying, Fan Sun, Yu-Cui Liao
|Apr 28, 2021
Role of Chronic Inflammatory Ratios in Predicting Recurrence of Resected Patients with Stage I-III Mucinous Colorectal Adenocarcinoma.Yu-Cui Liao, Hou-Qun Ying, Ying Huang
|Mar 18, 2021
Combined fibrinogen-to-pre-albumin ratio and carbohydrate antigen 19-9 score is a promising metric to predict progression of metastatic colorectal mucinous adenocarcinoma.Yu-Cui Liao, Ming Fu, Xue-Feng Wang
Pageof 2
